1st International Symposium on Hematopoietic Cell Transplantation-Related Toxicities

1st International Symposium on Hematopoietic Cell Transplantation-Related Toxicities Banner

Date & Location
Friday, April 27, 2018, 7:00 AM - Saturday, April 28, 2018, 1:00 PM, Zuckerman Research Center 417 E 68th St, New York, NY

Target Audience
Bone Marrow Transplant, Cardiology, Gastroenterology, Hematology & Oncology, Infectious Disease, Laboratory Medicine, Medical Oncology, Nephrology, Neurology, Pediatric Oncology, Pulmonary Medicine


More than 10,000 hematopoietic cell transplantations (HCT) are performed annually in the United States as a potentially curative treatment for over 70 life-threatening illnesses including hematologic cancers, genetic disorders, and other diseases. Despite significant advances in supportive care and improvements in HCT outcomes, 1 in every 3 patients may succumb to HCT-related toxicities, half of which are not related to graft-versus-host disease (GVHD). Following the successful examples of the international symposia focusing on GVHD and relapse after HCT, we are convening the '1st International Symposium on Hematopoietic Cell Transplantation-Related Toxicities.’

This symposium will bring together experts and thought leaders from around the world in the fields of HCT and related medical subspecialties. Speakers will discuss mechanisms of toxicities and symptom burden after HCT in order to identify best practices to both prevent and treat HCT-related toxicities. Over the 2-day symposium, speakers and attendees will also convene in dedicated sessions that will facilitate collaborative efforts in planning future research aimed at mitigating serious toxicities, reducing symptom burden, and improving patients’ outcomes.

Target Audience

The target audience for this symposium includes physicians, researchers, fellows, advanced practice providers, nurses, and pharmacists who provide care for patients undergoing HCT.

  1. Discuss the causes and mechanisms of toxicities and symptom burden after HCT in order to identify best practices to prevent and treat them.
  2. Understand the role of vascular endothelial cell damage as a key driver of many toxicities after HCT.


 Registration Fees   
 Physicians (MDs, PhDs, PharmDs and DOs)  $400
 Residents, Fellows    $200
 NPs, PAs, RNs, and Other Healthcare Providers        $250
 Industry Professionals*  $775

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact cme@mskcc.org at least one week prior to the course if you have any special dietary needs.

    • 30% Discounted Rate for MSK Alumni and MSK Alliance Members MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact cme@mskcc.org for more information or to register.
    • MSK Staff Registration Registration is complimentary for MSK staff. However, you must complete course registration to attend this course. 

    Cancellation Policy

    If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org).

    Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.


    Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    AMA Credit Designation

    Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Endothelial cells cover image credit: Kandasamy, Biomedical Microscopy Core, Paul D. Coverdell Center